Hypo-fractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer
Official Title of Study: A Study That Researches The Effects Of Hypo-Fractionated Stereotactic Body Radiotherapy For Newly Diagnosed Prostate Patients.
Objective of the study (lay terms): This study researches the effect of hypo-fractionated radiotherapy, also known as stereotactic body radiotherapy (SBRT), for newly diagnosed prostate cancer with no suspicion that the disease has spread outside of the prostate. This type of radiotherapy divides the total prescribed dose of radiation into fewer but larger doses as compared to conventional external beam radiotherapy. We hope to see that delivering higher, but more accurately targeted doses of radiation will be more effective and better tolerated than concurrent standard methods when used in treatment of patients.
For More Detailed Information, Contact: